Edwards Lifesciences Corporation Stock CINNOBER BOAT
Equities
0REN
US28176E1082
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -.--% | -.--% |
Jun. 20 | Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing | MT |
Jun. 17 | Edwards Lifesciences Corporation Announces Executive Changes | CI |
Sales 2024 * | 6.56B 5.89B | Sales 2025 * | 7.21B 6.47B | Capitalization | 55.66B 50B |
---|---|---|---|---|---|
Net income 2024 * | 1.61B 1.45B | Net income 2025 * | 1.88B 1.69B | EV / Sales 2024 * | 8.23 x |
Net cash position 2024 * | 1.67B 1.5B | Net cash position 2025 * | 2.8B 2.52B | EV / Sales 2025 * | 7.33 x |
P/E ratio 2024 * |
35
x | P/E ratio 2025 * |
29.7
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.59% |
Latest transcript on Edwards Lifesciences Corporation
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 14-12-31 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 13-12-31 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 16-07-04 |
Chairman | 67 | 14-11-12 | |
Steven Loranger
BRD | Director/Board Member | 72 | 16-03-15 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.00% | 185B | |
+31.86% | 158B | |
+33.21% | 113B | |
+2.28% | 64.32B | |
+0.11% | 48.41B | |
-6.76% | 37.82B | |
+0.78% | 35.57B | |
+11.28% | 28.12B | |
+15.70% | 23.58B |
- Stock Market
- Equities
- EW Stock
- 0REN Stock